11,034 Shares in Ingevity Corporation $NGVT Acquired by State of Wyoming

State of Wyoming bought a new position in shares of Ingevity Corporation (NYSE:NGVT) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 11,034 shares of the company’s stock, valued at approximately $824,000.

A number of other hedge funds have also bought and sold shares of the stock. AQR Capital Management LLC raised its holdings in shares of Ingevity by 10.9% in the first quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock worth $518,000 after buying an additional 1,323 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Ingevity by 5.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock valued at $863,000 after buying an additional 1,080 shares during the last quarter. Empowered Funds LLC grew its holdings in shares of Ingevity by 12.9% during the first quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock valued at $205,000 after buying an additional 594 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Ingevity by 311.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock valued at $23,769,000 after acquiring an additional 454,579 shares during the period. Finally, Jane Street Group LLC increased its position in shares of Ingevity by 306.1% in the 1st quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock valued at $3,519,000 after acquiring an additional 66,995 shares during the period. Institutional investors and hedge funds own 91.59% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Weiss Ratings upgraded Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. Wall Street Zen downgraded Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st. Two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $80.00.

Ingevity Stock Performance

NGVT opened at $76.53 on Friday. Ingevity Corporation has a 12-month low of $45.85 and a 12-month high of $79.29. The company has a current ratio of 1.61, a quick ratio of 1.15 and a debt-to-equity ratio of 22.52. The firm has a market capitalization of $2.63 billion, a PE ratio of 52.06 and a beta of 1.16. The firm has a 50 day moving average of $73.57 and a two-hundred day moving average of $71.65.

Ingevity (NYSE:NGVT) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, beating the consensus estimate of $1.33 by $0.41. The business had revenue of $314.10 million during the quarter, compared to analysts’ expectations of $312.20 million. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. On average, analysts anticipate that Ingevity Corporation will post 5.4 EPS for the current year.

Insider Buying and Selling

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total value of $33,971.04. Following the sale, the senior vice president directly owned 7,202 shares of the company’s stock, valued at approximately $493,264.98. This represents a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Ryan C. Fisher sold 2,709 shares of the stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $73.72, for a total value of $199,707.48. Following the sale, the senior vice president directly owned 15,722 shares in the company, valued at $1,159,025.84. This represents a 14.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 8,205 shares of company stock valued at $616,779 over the last 90 days. Insiders own 0.88% of the company’s stock.

Ingevity Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.